Soyoung Park, MD
Hematology & Oncology · Gilbert, AZNPI 1013279256
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,310 of the $3,609 with a category attached, or 64.0%. 13 manufacturers reported payments, led by Janssen Scientific Affairs, LLC at 49.5% of the total. Reporting peaked in 2023 at $1,674 and has fallen 59.1% since, to $685 in 2025. That places this record below the midpoint for hematology & oncology clinicians in AZ, where the typical reported total is $6,870.
Across 24 payments — averaging $150.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$2K
- Beigene, Ltd.$525
- Incyte Corporation$249
- Lilly USA, LLC$214
- Karyopharm Therapeutics Inc.$204
- Autolus Inc$144
- plus $488 from 7 others
What the payments were for
- Consulting fees$2,31064%
- Food & beverage$1,26835%
- Education$321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 2 | $1,785 |
| Beigene, Ltd. | 1 | $525 |
| Incyte Corporation | 3 | $249 |
| Lilly USA, LLC | 3 | $214 |
| Karyopharm Therapeutics Inc. | 5 | $204 |
| Autolus Inc | 1 | $144 |
| Bristol Myers Squibb | 2 | $143 |
| Rigel Pharmaceuticals, Inc. | 1 | $125 |
| CTI Biopharma Corp. | 1 | $106 |
| Pfizer | 2 | $42 |
| Novartis | 1 | $25 |
| GSK | 1 | $24 |
| Legend Biotech USA Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,609 in reported general payments places this provider in the 40th percentile of 261 hematology & oncology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxyurea | 13 | $567 |
| Acyclovir | 14 | $95 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Gilbert
- Sumit MadanGilbert$422K
- Jiaxin NiuGilbert$121K
- Yazan SamhouriGilbert$84K
- Matthew UlricksonGilbert$25K
- Santosh RaoGilbert$25K
- Qing ZhaoGilbert$25K
- Sujith KalmadiChandler$1.4M
- Jeffrey SchriberScottsdale$715K
- Javier MunozPhoenix$638K
- Tanios Bekaii-SaabScottsdale$527K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.